NCT01027208 - A Rollover Study of Ixabepilone (BMS-247550) In Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions

Metastatic Breast Cancer

Interventions

DRUG

Ixabepilone

Lyophilized and solvent, IV, 10-50 mg/m²

Trial Locations (14)

Local Institution, Nagoya

Local Institution, Kashiwa-Shi

Local Institution, Fukuoka

Local Institution, Saitama

Local Institution, Tokyo

Local Institution, Matabashi-Shi

Local Institution, Kagoshima

Local Institution, Isehara-Shi

Local Institution, Niigata

Local Institution, Iruma-Gun

Local Institution, Utsunomiya

Local Institution, Bunkyo-Ku

Local Institution, Chuo-Ku

Local Institution, Toshima-Ku